APA
Fryer R. M., Muthukumarana A., Chen R. R., Smith J. D., Mazurek S. N., Harrington K. E., Dinallo R. M., Burke J., DiCapua F. M., Guo X., Kirrane T. M., Snow R. J., Zhang Y., Soleymanzadeh F., Madwed J. B., Kashem M. A., Kugler S. Z., O'Neill M. M., Harrison P. C., Reinhart G. A. & Boyer S. J. (20120504). Mitigation of off-target adrenergic binding and effects on cardiovascular function in the discovery of novel ribosomal S6 kinase 2 inhibitors. : The Journal of pharmacology and experimental therapeutics.
Chicago
Fryer Ryan M, Muthukumarana Akalushi, Chen Rong Rhonda, Smith James D, Mazurek Suzanne Nodop, Harrington Kyle E, Dinallo Roger M, Burke Jennifer, DiCapua Frank M, Guo Xin, Kirrane Thomas M, Snow Roger J, Zhang Yunlong, Soleymanzadeh Fariba, Madwed Jeffrey B, Kashem Mohammed A, Kugler Stanley Z, O'Neill Margaret M, Harrison Paul C, Reinhart Glenn A and Boyer Stephen J. 20120504. Mitigation of off-target adrenergic binding and effects on cardiovascular function in the discovery of novel ribosomal S6 kinase 2 inhibitors. : The Journal of pharmacology and experimental therapeutics.
Harvard
Fryer R. M., Muthukumarana A., Chen R. R., Smith J. D., Mazurek S. N., Harrington K. E., Dinallo R. M., Burke J., DiCapua F. M., Guo X., Kirrane T. M., Snow R. J., Zhang Y., Soleymanzadeh F., Madwed J. B., Kashem M. A., Kugler S. Z., O'Neill M. M., Harrison P. C., Reinhart G. A. and Boyer S. J. (20120504). Mitigation of off-target adrenergic binding and effects on cardiovascular function in the discovery of novel ribosomal S6 kinase 2 inhibitors. : The Journal of pharmacology and experimental therapeutics.
MLA
Fryer Ryan M, Muthukumarana Akalushi, Chen Rong Rhonda, Smith James D, Mazurek Suzanne Nodop, Harrington Kyle E, Dinallo Roger M, Burke Jennifer, DiCapua Frank M, Guo Xin, Kirrane Thomas M, Snow Roger J, Zhang Yunlong, Soleymanzadeh Fariba, Madwed Jeffrey B, Kashem Mohammed A, Kugler Stanley Z, O'Neill Margaret M, Harrison Paul C, Reinhart Glenn A and Boyer Stephen J. Mitigation of off-target adrenergic binding and effects on cardiovascular function in the discovery of novel ribosomal S6 kinase 2 inhibitors. : The Journal of pharmacology and experimental therapeutics. 20120504.